MRI detection of intratumoral fat in hepatocellular carcinoma: Potential biomarker for a more favorable prognosis

American Journal of Roentgenology

Volumn 199, Issue 5, 2012, Pages 1018-1025

  Siripongsakun, Surachate ^a,b   Lee, Jeong K ^a,c   Raman, Steven S ^a   Tong, Myron J ^a   Sayre, James ^a   Lu, David S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Chalubhorn Hospital   (Thailand)

^c Ewha Womans University   (South Korea)

Author keywords

Fat; Hepatocellular carcinoma (HCC); MRI; Outcome; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; INTRATUMORAL FAT; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; TIME TO TUMOR PROGRESSION; TUMOR GROWTH;

ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84868031106     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.12.8632     Document Type: Article

References (17)

1. Tong MJ, Sun HE, Hsien C, Lu DS. Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: results from a community-based clinic. Dig Dis Sci 2010;55:826-835
2. Martín J, Sentís M, Zidan A, et al. Fatty metamorphosis of hepatocellular carcinoma: detection with chemical shift gradient-echo MR imaging. Radiology 1995;195:125-130
3. Kutami R, Nakashima Y, Nakashima O, Shiota K, Kojiro M. Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol 2000;33:282-289 (Pubitemid 30485232)
4. Kadoya M, Matsui O, Takashima T, Nonomura A. Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology 1992;183:819-825
5. Yu JS, Chung JJ, Kim JH, Kim KW. Fat-containing nodules in the cirrhotic liver: chemical shift MRI features and clinical implications. AJR 2007;188:1009-1016 (Pubitemid 46496933)
6. Emile JF, Lemoine A, Azoulay D, Debuire B, Bismuth H, Reynes M. Histological, genomic and clinical heterogeneity of clear cell hepatocellular carcinoma. Histopathology 2001;38:225-231 (Pubitemid 32862732)
7. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-1022
8. Clark HP, Carson WF, Kavanagh PV, Ho CP, Shen P, Zagoria RJ. Staging and current treatment of hepatocellular carcinoma. RadioGraphics 2005;25 [suppl 1]: S3-S23 (Pubitemid 41686059)
9. Kim KW, Lee JM, Choi BI. Assessment of the treatment response of HCC. Abdom Imaging 2011;36:300-314
10. Dancey JE, Dodd LE, Ford R, et al. Recommendations for the assessment of progression in randomised cancer treatment trials. Eur J Cancer 2009;45:281-289
11. Kajiwara M. MR imaging of small hepatocellular carcinoma (< or = 20 mm): correlation with vascularity and histological features. Kurume Med J 1997;44:327-338 (Pubitemid 128516382)
12. Kao WY, Su CW, Chau GY, Lui WY, Wu CW, Wu JC. A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery. World J Surg 2011;35:858-867
13. Kondo K, Chijiiwa K, Funagayama M, Kai M, Otani K, Ohuchida J. Differences in long-term outcome and prognostic factors according to viral status in patients with hepatocellular carcinoma treated by surgery. J Gastrointest Surg 2008;12:468-476
14. Chen CH, Huang GT, Yang PM, et al. Hepatitis B-and C-related hepatocellular carcinomas yield different clinical features and prognosis. Eur J Cancer 2006;42:2524-2529
15. Li Q, Li H, Qin Y, Wang PP, Hao X. Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Chinese experience. J Gastroenterol Hepatol 2007;22:1936-1941 (Pubitemid 47525057)
16. Lencioni R, Llovet J. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010;30:52-60
17. Saad ED, Katz A. Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined. Ann Oncol 2009;20:460-464